Frank T. Watkins - Jun 21, 2022 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Frank T. Watkins
Stock symbol
SWAV
Transactions as of
Jun 21, 2022
Transactions value $
-$484,289
Form type
4
Date filed
6/21/2022, 07:12 PM
Previous filing
May 23, 2022
Next filing
Jun 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale -$80K -500 -2.4% $159.96 20.3K Jun 21, 2022 Direct F1, F2
transaction SWAV Common Stock Sale -$274K -1.7K -8.37% $161.33 18.6K Jun 21, 2022 Direct F1, F3
transaction SWAV Common Stock Sale -$130K -800 -4.3% $162.56 17.8K Jun 21, 2022 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 12/1/2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $159.77 to $160.67. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $160.77 to $161.69. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $161.95 to $162.93. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.